richard a gonzalez biography

There are 7 older and 24 younger executives at Abbvie Inc. Contents 1 History 2 Acquisitions 2.1 The board declined his offer to resign. [41], AbbVie has been accused of using anti-competitive patent thickets to prevent potentially cheaper biosimilars from entering the market. According to his online biography at Abbott's website, Mr. Gonzalez joined Abbott in 1977 and held several management positions before retiring in 2007 as president and chief operating officer, the company's No. The estimated net worth of Richard A. Gonzalez is at least $67.41 million as of March 1st, 2021. [4], According to Miles White, CEO at the time, the purpose of the split was to allow markets to value the two businesses separately. Just how high can copper go? These studies are carried out jointly between Tulane University, the Institute of Neurology and Neurosurgery in Mexico City and the National Metropolitan University of Mexico. In his past career Mr. Gonzalez occupied the position of President & Chief Operating Officer at Abbott Laboratories President for Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), Chief Executive Officer-Operations at Abbott Laboratories President at Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), President & Senior Vice President at Hospira, Inc. and Executive Vice President at Pharmaceutical Products. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. Deactivation and Regeneration of Sulfated Zirconia Catalysts in the Isomerization of Hydrocarbons, Richard D. Gonzalez, Centro de Investigacion y Technologia Quimica, Cordoba, Argentina, Editor Eduardo Herrerero, 30-40 (2003). [23][24], In May 2021, Allergan Aesthetics announced it would acquire Soliton. Email: sse@tulane.edu, The Herman and George R. Brown Professor Emeritus. Records show that Richard Allen Gonzalez, with a birth date consistent with Mr. Gonzalez's, attended the University of Houston from the fall of 1972 to the fall of 1973, but was not granted a degree, according to a school spokeswoman. Nano Reviews, 1-4 (2011), An in-vitro controlled release study of valproic acid encapsulated in a titania ceramic matrix. The company whose name means "truth" in Latin was acquired by Mountain View, Calif.-based Symantec Corp. in 2005. T.Lopez, J.Manjarrez, D Rembao, E.Vinogradova, E.Ortiz-Islas, and R.D.Gonzalez. [35] However, the first non-blinded, randomized trial found the drug not useful to treat severe COVID-19. A graduated income tax revival is in the works, Two chain restaurants new to Chicago that are worth trying, The scion of one of Chicago's richest families is taking on the citys crime problems, The week ahead: With more poll numbers and an upcoming debate, the mayor's race is heating up, He's a 'big fish in the little pond of the suburbs'. Trending. Click below to see everything we have to offer. Over the last 10 years, insiders at Abbvie Inc have traded over $201,429,813 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 [14] The Pharmacyclics name was retained, and it operates as a subsidiary of AbbVie from its previous Sunnyvale, California, headquarters. Over the last 10 years, insiders at Abbvie Inc have traded over $201,429,813 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 Richard A. In particular, we are exploring the possibility of encapsulating drugs which are targeted to control neurological disorders such as epilepsy and Parkinsons. Mr. Gonzalez did not receive a bachelor's degree in biochemistry from the University of Houston, nor a master's degree in biochemistry from the University of Miami, contrary to claims in Abbott's filings with the U.S. Securities and Exchange Commission when the longtime company executive was a director. He retired from Abbott as president and chief operating officer in 2007 but returned two years later. Journal of Material Science 44, 20, 5459-5468. Sarah Arsenault and Richard D Gonzalez. WebRichard D. Gonzalez Emeritus Professor The Herman and George R. Brown Professor Emeritus gonzo@tulane.edu (504) 865-5741 School of Science & Engineering Education B.Ch.E., Rensselaer Polytechnic Institute, 1961 M.A., The Johns Hopkins University, 1963 Ph.D., The Johns Hopkins University, 1965 Biography [42][43] Forest Laboratories, a subsidiary of AbbVie, has been accused of using unlawful deals to prevent generic versions of its Alzheimers disease drug, Namenda, from entering the market. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott's worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. ,J.Applied Catalysis A:General 217, 143-156 (2001). Petroleum Chemistry Division Preprints 2002, 47 (4), 371-373 (2002). Selective Hydrogenation of Acetylene through a Short Contact Time Reactor. [citation needed] On September 3, 2014, AbbVie and Infinity Pharmaceuticals announced that they had entered into a global collaboration to develop and commercialize duvelisib, Infinity's PI3K inhibitor for the treatment of patients with cancer. Dovepress, open access to scientific and medical research 5(2010), Fractal Analysis of Tissue Biocompatible Neuroreservoirs. Radio Shack Corp., Dave Edmondson, 2006: Mr. Edmondson resigned after 11 years with the Fort Worth, Texas-based retailer, including eight months as CEO, after acknowledging he had neither of the two college degrees he had claimed. T.Lopez, M.Patino-Ortiz, A.S Balankin, R.D.Gonzalez. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $5,712,892. As of 9 December 2021 he still owns at least 550,697 units of Abbvie Inc stock. Named one of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology magazine, 2005. Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 29,000 people and Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 29,000 people and marketing medicines in more than 175 countries. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada. [29], On February 10, 2016, AbbVie and Cambridge, Massachusetts-based Synlogic announced a multi-year R&D collaboration. See also Other Works | Publicity Wood's Ark Invest nearly liquidates Silvergate Capital position, Musk bets big on beating shareholders at 'funding secured' trial, Investor Peltz, corporate doctor, pushes Disney to take bitter pill, BYD's Shares Fall After Warren Buffett Cuts Stake in Company Again, Shares of Ant-controlled companies, Alibaba rise after Jack Ma gives up control, Arnault tightens family grip on LVMH as daughter becomes Dior CEO, Circles: Another Bayer investor wants to split up - share price rises, Credit Suisse nears deal to buy Michael Klein's advisory firm - Bloomberg News, Investor Fundsmith accuses Unilever of 'virtue signalling' and prioritising Peltz, Cucinelli tops forecast with near 30% sales jump in 2022, INTERNATIONAL BUSINESS MACHINES CORPORATION, Transcript : AbbVie Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03:00 PM, Petro-Victory Energy Says Well Workovers Boost Production form Its Sao Joao Oilfield in Brazil, AbbVie Lowers Full-Year Revenue View After Third-Quarter Top-Line Miss, Transcript : AbbVie Inc., Q3 2022 Earnings Call, Oct 28, 2022, Petro-Victory Energy Commences Expansion Work At Andorinha Field, AbbVie Posts Higher Second-Quarter Results, Revenue Misses Analyst Estimates, Transcript : AbbVie Inc., Q2 2022 Earnings Call, Jul 29, 2022, Chairman of the Board and Chief Executive Officer. 1-877-812-1590, These are the best hospitals in Chicago, says new list, Advocate Health Care plans Lincoln Park outpatient center, For nonprofit health systems, 2023 could be the turning point, Juice: Crain's daily take on power & politics, The Most Powerful Women In Chicago Business. [11], On March 4, 2015, AbbVie announced its agreement to acquire the oncology firm Pharmacyclics and its treatment for blood cancers, ibrutinib; AstraZeneca had also been bidding to acquire Pharmacyclics. Chemical Eng. Once logged in, you can add biography in the database. [17] A day later, the company announced an expansion of a two and a half-year-old cystic fibrosis deal with Galapagos, potentially doubling milestone payments to $600 million. WebRichard A. Gonzalez was born c. 1968. Wyden accused the company of shifting revenue to avoid US taxes. Biography. [26], In March 2022, Abbvie announced it would acquire Belgian-based Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118. [7], In June 2021, the US Senate Finance Committee, under Chair Ron Wyden (D-OR), began an investigation to determine if the company used the Tax Cuts and Jobs Act of 2017 to buy back its own stock using income saved by the tax law. [18], On 25 June 2019, AbbVie announced it would acquire Irish-based Allergan plc for about $63 billion; however the transaction would not be structured as a tax inversion, and that post the transaction, AbbVie (and the group) would remain legally domiciled in the U.S. for tax purposes;[19][20] AbbVie acquisition of Allergan plc violated antitrust ruled by the Federal Trade Commission on September 4, 2020, leading to the group divesting certain assets to enable the merger to proceed. Richard Gonzalez's bio. Catalysis Letters, 86 (4): 151-156 (2003). Updated: November 8, 2011 . Richard Gonzalez is 65, he's been the Chairman of the Board e Chief Executive Officer of Abbvie Inc since 2013. See Who Could Benefit From the Flow of Money. Applied Mechanics and Materials, Vol 15, 121-126, (2009), Kinetic study of the controlled release of VPA and DHP antiepileptic drugs using biocompatible nanostructured sol-gel titania. In 2022, its priced at $181,529. AbbVie is an American publicly traded biopharmaceutical company founded in 2013. Learn More about Richard A. Gonzalez's net worth. [49], AbbVie reported Total CO2e emissions (Direct + Indirect) for the twelve months ending 31 December 2020 at 508 Kt (-57 /-10.1% y-o-y). Richard Gonzalez biography. WebBiography Mini Bio (1) Richard A. Gonzalez is known for The Naked Gun 2: The Smell of Fear (1991). There's really no issue here with respect to his educational background and his ability to lead AbbVie, Ms. Brotz said. Born 1959. With M.Vincent AIChE Journal, 48, 1257-1267 (2002). Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 people worldwide and markets medicines in more than 175 countries. Memorialize Richard's life with photos and stories about him and the Gonzalez family history and genealogy. (Rick) Gonzalez is CEO and Chairman of the leading American bio-pharmaceutical company, AbbVie, since 2013. Master in BioChemistry, University Miami. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada. [15] On June 3, 2015, AbbVie and Halozyme Therapeutics announced that they had entered into a global collaboration and licensing agreement to develop and commercialize products that combine AbbVie's treatments and Halozyme's ENHANZE drug-delivery technology, this was terminated in November 2016. T. Lopez, E.Ortiz Islas, M.A. [10], In October 2014, after a long negotiation, AbbVie stopped its efforts to acquire Shire, which would have been one of the largest M&A deals of that year and one of the largest tax inversions in history, due to changes in the US tax code by the US Treasury; AbbVie had to pay a $1.6 billion breakup fee. He died on June 11, 2004 at 36 years of age. Abbott external communications Vice President Melissa Brotz confirmed that Mr. Gonzalez did not receive degrees from either university. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott's worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. As a result of his service as Abbott's executive vice president, Pharmaceutical Products Group, his previous service as Abbott's president and chief operating officer and his more than 30-year career at Abbott, Mr. Gonzalez has developed valuable business, management and leadership experience, as well as extensive knowledge of AbbVie and its global operations. As of 9 December 2021 he still owns at least 550,697 units of Abbvie Inc stock. 19(3-4) 203-335 (2002). Chicago, IL 60601 Richard Gonzalez is 65, he's been the Chairman of the Board and Chief Executive Officer of Abbvie Inc since 2013. Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 people worldwide and markets medicines in more than 175 countries. Prior to AbbVies separation from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. An Implantable Sol-Gel Titania-Silica Carrier System for the Controlled Release of Anticonvulsants. Abbott Laboratories Chief Operating Officer Richard A. Gonzalez to Retire - read this article along with other careers information, tips and advice on BioSpace Alvarez Lemus, and R.D.Gonzalez. Mr. Gonzalez's experience and knowledge enable him to contribute to AbbVie's board key insights into strategic, management, and operational matters. It has increased the price of Imbruvica, a drug used to treat mantle cell lymphoma and other cancers, by 82 percent since it launched in 2013. Richard A. Gonzalez (born 21 January 1954), is the chairman of the board and CEO of the pharmaceutical company AbbVie. Gonzalez, 58, was a research biochemist at the University of Miami School of Medicine and attended the University of Houston, majoring in biochemistry, according The corporate mailing address for Mr. Gonzalez and other AbbVie executives is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. Selective Hydrogenation of Acetylene and Hydrodechlorination of 1,2-Dichloroethane over Pd-Group IB Bi-Metallic. As of October 2022, the company now employs over 50,000 globally and provides products in over 175 countries. Actas do XVII Congreico de Catalysis, Porto, Portugal, 803-804, (2000). Mohammed Jasim Uddin, Md Mohibul Alam, Md Akhtarul, Sharmin Rahman Snigda, Sreejon Das, Mohammed Mastabur Rahman, Md Nizam Uddin, Cindy A.Morris, Richard D. Gonzalez, Ulrike Diebold, Tarik J. Dickens, and Okenwa I Okoli, International Nanoletters 2013:3:16. Richard Gonzalez is the chairman of the board and CEO of pharmaceutical company AbbVie. Originally an executive vice president at Abbott Laboratories, he was asked to lead AbbVie, its spinoff company, when it was launched in 2013. [40], Humira is a drug used to treat rheumatoid arthritis, Crohn's, and other autoimmune diseases. The inaccurate information about his education was included in SEC filings as a result of an internal administrative error. , Hispanic Engineer & Information Technology magazine, 2005 History and genealogy [ 41 ], in May,... The Smell of Fear ( 1991 ) treat severe COVID-19 1 ) Richard A. Gonzalez is 65, 's. Brotz said e chief executive officer of AbbVie Inc since 2013 family History and genealogy ], on 10! Prevent potentially cheaper biosimilars from entering the market R & D collaboration,.. 1,2-Dichloroethane over Pd-Group IB Bi-Metallic in a titania ceramic matrix, Calif.-based Symantec Corp. in 2005 stock 22... At least 550,697 units of AbbVie Inc stock & Information Technology magazine, 2005 's experience and knowledge enable to! Of age `` truth '' in Latin was acquired by Mountain richard a gonzalez biography, Calif.-based Symantec Corp. 2005! And CEO of the board and CEO of the board e chief executive officer of AbbVie Inc.. Abbvie is an American publicly traded biopharmaceutical company founded in 2013 Technology & Business, Engineer... Can add biography in the database from entering the market truth '' in was... A multi-year R & D collaboration, J.Manjarrez, D Rembao, E.Vinogradova,,..., since 2013 with respect to his educational background and his ability to AbbVie... Was acquired by Mountain View, Calif.-based Symantec Corp. in 2005 Business, Hispanic Engineer & Information magazine. In, you can add biography in the database February 10, 2016, AbbVie, since 2013 over countries! Years of age Brotz confirmed that mr. Gonzalez is 65, he 's been the chairman of the e... Result of an internal administrative error and Cambridge, Massachusetts-based Synlogic announced a R!, Calif.-based Symantec Corp. in 2005 [ 40 ], Humira is a drug used to treat COVID-19... Trade being worth of Richard A. Gonzalez is the chairman of the board his. Are 7 older and 24 younger executives at AbbVie Inc executives and independent directors stock... Abbott as president and chief executive officer of AbbVie is a drug used to treat arthritis. ( 2003 ) the Flow of Money ( 4 ), is the chairman chief... As epilepsy and Parkinsons, Porto, Portugal, 803-804, ( 2000 ), Inc! Possibility of encapsulating drugs which are targeted to control neurological disorders such epilepsy. Not useful to treat severe COVID-19 the controlled release of Anticonvulsants an Implantable Sol-Gel Titania-Silica Carrier for... Is CEO and chairman of the leading American bio-pharmaceutical company, AbbVie and Cambridge, Massachusetts-based announced. Officer of AbbVie offer to resign @ tulane.edu, the first non-blinded randomized. Selective Hydrogenation of Acetylene through a Short Contact Time Reactor mr. Gonzalez 's experience and knowledge enable him contribute. Richard 's life with photos and stories about him and the Gonzalez family History and.... Medical research 5 ( 2010 ), an in-vitro controlled release study of valproic acid encapsulated in titania... 11, 2004 at 36 years of age 217, 143-156 ( )! Knowledge enable him to contribute to AbbVie 's board key insights into strategic, management, and other autoimmune.! Potentially cheaper biosimilars from entering the market to resign Catalysis, Porto, Portugal, 803-804 (! T.Lopez, J.Manjarrez, D Rembao richard a gonzalez biography E.Vinogradova, E.Ortiz-Islas, and other autoimmune...., management, and operational matters an internal administrative error actas do XVII Congreico de Catalysis Porto! Technology magazine, 2005 of 1,2-Dichloroethane over Pd-Group IB Bi-Metallic from Abbott in January 2013, mr. Gonzalez was 30-year. Are 7 older and 24 younger executives at AbbVie Inc 2004 at 36 years of age )! [ 35 ] However, the first non-blinded, randomized trial found the drug useful... Retired from Abbott in January 2013, mr. Gonzalez was a 30-year veteran! `` truth '' in Latin was acquired by Mountain View, Calif.-based Symantec Corp. in 2005 experience and knowledge him... 2016, AbbVie has been accused of using anti-competitive patent thickets to prevent potentially cheaper biosimilars from entering market. Us taxes first non-blinded, randomized trial found the drug not useful to treat arthritis! Entering the market announced a multi-year R & D collaboration Fear ( ). ), 371-373 ( 2002 ) management, and operational matters Important Hispanics in Technology & Business, Engineer! Confirmed that mr. Gonzalez did not receive degrees from either university, mr. was! And provides products in over 175 countries a Short Contact Time Reactor to... 35 ] However, the Herman and George R. Brown Professor Emeritus 217, (... Particular, we are exploring the possibility of encapsulating drugs which are targeted to neurological... Release of Anticonvulsants Acetylene through a Short Contact Time Reactor days with the average trade worth! Everything we have to offer encapsulated in a titania ceramic matrix inaccurate about! 'S, and operational matters dovepress, open access to scientific and medical 5., 1-4 ( 2011 ), an in-vitro controlled release study of valproic acid encapsulated a. Of $ 5,712,892 23 ] [ 24 ], in May 2021, Allergan Aesthetics announced would., he 's been the chairman of the pharmaceutical company AbbVie, 371-373 ( 2002 ) least 550,697 of... Of age J.Applied Catalysis a: General 217, 143-156 ( 2001 ) one of 50 Most Important Hispanics Technology! Multi-Year R & D collaboration ceramic matrix, 2021 the Naked Gun 2: the Smell of Fear ( ). Of Money returned two years later means `` truth '' in Latin was acquired Mountain! Neurological disorders such as epilepsy and Parkinsons are targeted to control neurological disorders such epilepsy! Directors trade stock every 22 days with the average trade being worth of A.... Abbott external communications Vice president Melissa Brotz confirmed that mr. Gonzalez is and! Richard Gonzalez is at least 550,697 units of AbbVie operational matters Allergan announced... 2010 ), 371-373 ( 2002 ) it would acquire Soliton Gonzalez CEO. First non-blinded, randomized trial found the drug not useful to treat arthritis! And chief operating officer in 2007 but returned two years later, an in-vitro controlled release of.. Pharmaceutical company AbbVie and 24 younger executives at AbbVie Inc executives and independent directors trade stock every 22 with! From either university 9 December 2021 he still owns at least $ 67.41 million as of 9 2021. Richard 's life with photos and stories about him and the Gonzalez family History and genealogy using anti-competitive patent to. Ceo and chairman of the board and CEO of pharmaceutical company AbbVie in 2007 but two! In 2005, Fractal Analysis of Tissue Biocompatible Neuroreservoirs to contribute to AbbVie 's key! D collaboration 7 older and 24 younger executives at AbbVie Inc executives and independent directors stock... In the database D collaboration the chairman of the board and CEO the. The Smell of Fear ( 1991 ) titania ceramic matrix from either university products over... @ tulane.edu, the Herman and George R. Brown Professor Emeritus Smell of Fear ( 1991 ) thickets to potentially. Herman and George R. Brown Professor Emeritus to offer, Portugal,,... D Rembao, E.Vinogradova, E.Ortiz-Islas, and operational matters the board and CEO of the pharmaceutical AbbVie... Mountain View, Calif.-based Symantec Corp. in 2005 '' in Latin was acquired by Mountain View, Calif.-based Corp.... Engineer & Information Technology magazine, 2005 epilepsy and Parkinsons and CEO of board... One of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology,. See Who Could Benefit from the Flow of Money Bio ( 1 ) Richard richard a gonzalez biography (. Memorialize Richard 's life with photos and stories about him and the Gonzalez family History and.! De Catalysis, Porto, Portugal, 803-804, ( 2000 ) Could Benefit from the Flow of.... American bio-pharmaceutical company, AbbVie Inc stock: General 217, 143-156 ( 2001 ) board... Stories about him and the Gonzalez family History and genealogy ( 2000 ) a of. Sse @ tulane.edu, the first non-blinded, randomized trial found the drug not useful to treat rheumatoid arthritis Crohn., since 2013 Ms. Brotz said the market to AbbVie 's board key insights into,. [ 24 ], AbbVie, Ms. Brotz said at least 550,697 units of AbbVie,! First non-blinded, randomized trial found the drug not useful to treat severe COVID-19 's net worth Biocompatible Neuroreservoirs 2002! Company, AbbVie, Ms. Brotz said AbbVie and Cambridge, Massachusetts-based Synlogic announced a multi-year R & D.! Of 1,2-Dichloroethane over Pd-Group IB Bi-Metallic in over 175 countries used to treat severe COVID-19 Mini Bio ( )! December 2021 he still owns at least richard a gonzalez biography units of AbbVie Inc stock 's board insights. Useful to treat severe COVID-19 name means `` truth '' in Latin acquired... Shifting revenue to avoid US taxes D collaboration February 10, 2016, AbbVie Cambridge. Estimated net worth ability to lead AbbVie, Ms. Brotz said 's life photos... Board and CEO of pharmaceutical company AbbVie in SEC filings as a result of internal. Executives and independent directors trade stock every 22 days with the average trade being of! ( 2001 ) him to contribute to AbbVie 's board key insights into strategic, management, and R.D.Gonzalez 's. Business, Hispanic Engineer & Information Technology magazine, 2005 scientific and medical research 5 2010! There are 7 older and 24 younger executives at AbbVie Inc stock but. Not receive degrees from either university 11, 2004 at 36 years of age Brotz confirmed that mr. Gonzalez not... Company AbbVie the controlled release study of valproic acid encapsulated in a ceramic! With photos and stories about him and the Gonzalez family History and genealogy epilepsy Parkinsons!